Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Explore linked clinical trials.22 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Digital Patient-Reported Assessment in Older Adults With Acute Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myeloid leukemia, neoplasm | Not yet recruiting | Not applicable | 2026-10-07 | NCT07597590 | |
| Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia | Acute Schizophrenia | Recruiting | Phase 3 | 2026-09-16 | NCT05325645 | |
| REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Not yet recruiting | Not stated | 2026-09-09 | NCT07792252 | |
| Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Active, not recruiting | Phase 2 | 2026-07-08 | NCT03828201 | |
| Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure. | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not stated | 2026-06-22 | NCT05712746 | |
| Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Recruiting | Not stated | 2026-06-22 | NCT05342493 | |
| Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADH | Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, brain disorder, central nervous system disorder, endocrine system disorder, hypothalamic disorder, inappropriate ADH syndrome, metabolic disease, nervous system disorder, pituitary gland disorder | Active, not recruiting | Not stated | 2026-06-22 | NCT04790175 | |
| Kaempferol Absorption and Pharmacokinetics Evaluation | Healthy Volunteers; Longevity; Mitochondria Health; No Disease; Pharmacokinetics and Biological Absorption of Kaempferol in Healthy Adult | Recruiting | Not applicable | 2026-03-23 | NCT07322406 | |
| A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Recruiting | Phase 3 | 2026-01-14 | NCT07225712 | |
| A Long-term Trial of EB-1020 in Pediatric Patients With ADHD | attention deficit hyperactivity disorder, inattentive type, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorder | Recruiting | Phase 3 | 2025-12-23 | NCT07087327 | |
| A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD | attention deficit hyperactivity disorder, inattentive type, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorder | Recruiting | Phase 2 / Phase 3 | 2025-12-23 | NCT07086313 | |
| Software as a Medical Device for the Treatment of Patients With PTSD | Stress Disorders, Traumatic, acute stress disorder, combat disorder, psychiatric disorder | Recruiting | Phase 2 / Phase 3 | 2025-11-21 | NCT06589505 | |
| A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Not yet recruiting | Phase 3 | 2025-09-22 | NCT07184645 | |
| LUPKYNIS Drug-use Results Survey | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder | Recruiting | Not stated | 2025-09-19 | NCT07053891 | |
| A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Not yet recruiting | Phase 3 | 2025-09-15 | NCT07173478 | |
| A Pilot Study to Evaluate Equol and Its Effects on Menopausal Symptoms Experienced by Women in Singapore | Menopause | Recruiting | Not stated | 2025-08-22 | NCT07136220 | |
| Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients | attention deficit hyperactivity disorder, inattentive type, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorder | Recruiting | Phase 2 / Phase 3 | 2025-08-03 | NCT06931080 | |
| A Long-term Trial of EB-1020 in Adult Patients With ADHD | attention deficit hyperactivity disorder, inattentive type, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorder | Recruiting | Phase 3 | 2025-08-03 | NCT06926829 | |
| Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, depressive disorder, psychiatric disorder | Recruiting | Not stated | 2025-07-08 | NCT05962216 | |
| REXULTI Drug General Use-results Survey (Excessive Motor Activity or Physically/Verbally Aggressive Behavior Due to Rapid Changes in Mood, Irritability, and/or Outbursts Associated With Dementia Due to Alzheimer's Disease) | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not stated | 2025-07-02 | NCT06875986 | |
| Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes | Lower-risk Myelodysplastic | Active, not recruiting | Phase 1 | 2025-03-20 | NCT03906695 | |
| Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas | Disease Attributes, Hemic and Lymphatic Diseases, Lymphoma, Extranodal NK-T-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2022-08-18 | NCT02859402 |